EP Patent

EP2992903B8 — Combination of a naloxol-peg conjugate and an opioid agonist

Assigned to AstraZeneca AB · Expires 2022-06-08 · 4y expired

What this patent protects

Patent listed against naloxegol-oxalate.

Drugs covered by this patent

naloxegol-oxalate (NALOXEGOL OXALATE)

Patent Metadata

Patent number: EP2992903B8
Jurisdiction: EP
Classification: —
Expires: 2022-06-08
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.